52 Week Range
As of on the NASDAQ ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Fluent Beverage Co Announces Plans To Commercialize Non-Alcohol CBD-Infused Beverages In Canada
Tilray And Privateer Holdings Sign Deal To Extend Lock-Up And Provide For Orderly Distribution Of 75 Million Tilray Shares Held By Privateer
Tilray Announces Definitive Agreement To Acquire FOUR20 Adult-Use Cannabis Retailer
Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.
Biotechnology & Drugs
1100 Maughan Rd
President, Chief Executive Officer, Director
Chief Financial Officer, Treasurer, Secretary
Executive Vice President, Corporate Affairs
Edward Wood Pastorius
Chief Revenue Officer
Chief Corporate Development
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Canadian pot producer Tilray Inc <TLRY.O> reported a bigger quarterly loss on Tuesday, as it ramped up investments to boost production in an attempt to grab a larger share of the nascent cannabis market and expand internationally.
Canadian pot producer Tilray Inc reported a wider-than-expected quarterly loss on Tuesday, as it ramped up investments to boost production and warned of muted growth in the Canadian recreational marijuana market for the second half of the year.
Cannabis producer Tilray Inc will not make profit for at least another year, Bloomberg reported on Monday, quoting the company's chief financial officer.
Cannabis producer Tilray Inc will not generate positive earnings for at least another year, Bloomberg reported https://www.bloomberg.com/news/articles/2019-06-10/tilray-won-t-be-profitable-for-at-least-a-year-cfo-says on Monday, quoting the company's chief financial officer.
Cannabis producers Tilray Inc and Aurora Cannabis Inc on Tuesday reported a surge in quarterly revenue, boosted by increased demand following the legalization of recreational cannabis in Canada.
Canada's Tilray Inc reported a bigger quarterly loss on Tuesday, as the cannabis producer ramped up investments, acquired a hemp-based food maker and expanded internationally.
Shares of Canadian cannabis firm Tilray Inc rose as much as 7 percent on Wednesday after announcing a deal to buy hemp food maker Manitoba Harvest for up to C$419 million ($318 million) as it seeks to gain a foothold in the lucrative business.
Anheuser-Busch InBev <ABI.BR>, the world's largest brewer, and Canadian pot producer Tilray Inc <TLRY.O> are partnering in a $100-million joint venture to research cannabis-infused non-alcoholic drinks for the Canadian market, the companies said Wednesday.
Canadian cannabis producer Tilray Inc <TLRY.O> reported an 86 percent jump in third-quarter revenue on Tuesday, but a wider-than-expected loss weighed on shares in after-hours trading.
Canadian cannabis producer Tilray Inc said on Tuesday its third-quarter revenue rose 86 percent to $10 million (13.24 million Canadian dollars), compared with the consensus analyst estimate of $10.1 million.
Andrew Left, one of Wall Street's most prominent short-sellers, said Tilray Inc gave his firm its "worst day ever in the market" two months ago when its shares almost doubled in one session, but he remains bearish on the Canadian cannabis company.
The meteoric rise this week of Tilray Inc's <TLRY.O> share price unleashed a rush of speculative activity in options on the medical marijuana company and other marijuana-related names, data showed on Wednesday.
Tilray Inc <TLRY.O>, which listed on the Nasdaq on July 19, rose 3.9 percent in after hours trade on Tuesday after reporting its second-quarter revenue almost doubled to $9.7 million (12.66 million Canadian dollars).
Canadian cannabis producer Tilray Inc said on Tuesday its second-quarter revenue almost doubled to $9.7 million (12.66 million Canadian dollars), beating analyst expectations for $9 million.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.